Skip to main content

Advertisement

Log in

Peritoneal Cell-free DNA: an innovative method for determining acute cell damage in peritoneal membrane and for monitoring the recovery process after peritonitis

  • Original Article
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

Abstract

Background

Cell-free DNA (cfDNA) is present in the peritoneal effluent of stable peritoneal dialysis (PD) patients, but there are no data on cfDNA in PD patients with peritonitis. We investigated the variation of peritoneal cfDNA levels subsequent to peritonitis in PD patients.

Methods

We enrolled 53 PD patients: 30 without any history of systemic inflammation or peritonitis in the last 3 months (group A) and 23 with acute peritonitis (group B). CfDNA was quantified in the peritoneal effluent. Peritoneal samples on days 1, 3, 10, 30 and until day 120 from the start of peritonitis were collected for white blood cells (WBC) count and cfDNA evaluation in group B.

Results

Quantitative analysis of cfDNA showed significantly higher levels in group B on day 1, 3, 10 and 30 compared with group A (p < 0.05). A significant positive correlation was observed between cfDNA concentration and WBC on day 1 (rho = 0.89) and day 3 (rho = 0.5) (both, p < 0.05). However, no significant correlation was observed between cfDNA and WBC on days 10 and 30. In group B, peritoneal cfDNA levels tended to progressively decline during follow-up of peritonitis. From this decreasing curve, we estimated that 49 days are necessary to reach the value of 51 genome equivalents (GE)/ml (75th percentile in controls) and 63 days to reach 31 GE/ml (median).

Conclusion

Our results demonstrate that cfDNA increases in peritoneal effluent of PD patients with peritonitis and tends to progressively decline in step with peritonitis resolution and membrane repair process. Peritoneal cfDNA quantification could be an innovative method to determine acute damage and an inverse index of the repair process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, Johnson DW, Kuijper EJ, Lye WC, Salzer W, Schaefer F, Struijk DG (2010) Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 30:393–423

    Article  PubMed  Google Scholar 

  2. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, Kuijper EJ, Li PK, Lye WC, Mujais S, Paterson DL, Fontan MP, Ramos A, Schaefer F, Uttley L (2005) Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 25:107–131

    PubMed  Google Scholar 

  3. Brown EA (2005) Peritonitis: limiting the damage. Nephrol Dial Transplant 20:1539–1541

    Article  PubMed  Google Scholar 

  4. Lai KN, Leung JC (2010) Inflammation in peritoneal dialysis. Nephron Clin Pract. 116:c11–c18

    Article  PubMed  CAS  Google Scholar 

  5. Aroeira LS, Aguilera A, Sanchez-Tomero JA, Bajo MA, del Peso G, Jimenez-Heffernan JA, Selgas R, Lopez-Cabrera M (2007) Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 18:2004–2013

    Article  PubMed  CAS  Google Scholar 

  6. Lam MF, Leung JC, Lo WK, Tam S, Chong MC, Lui SL, Tse KC, Chan TM, Lai KN (2007) Hyperleptinaemia and chronic inflammation after peritonitis predicts poor nutritional status and mortality in patients on peritoneal dialysis. Nephrol Dial Transplant 22:1445–1450

    Article  PubMed  CAS  Google Scholar 

  7. Lichtenstein AV, Melkonyan HS, Tomei LD, Umansky SR (2001) Circulating nucleic acids and apoptosis. Ann NY Acad Sci 945:239–249

    Article  PubMed  CAS  Google Scholar 

  8. Stroun M, Lyautey J, Lederrey C, Olson-Sand A, Anker P (2001) About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta 313:139–142

    Article  PubMed  CAS  Google Scholar 

  9. Atamaniuk J, Kopecky C, Skoupy S, Saemann MD, Weichhart T (2012) Apoptotic cell-free DNA promotes inflammation in haemodialysis patients. Nephrol Dial Transplant 27:902–905

    Article  PubMed  CAS  Google Scholar 

  10. Jung K, Fleischhacker M, Rabien A (2010) Cell-free DNA in the blood as a solid tumor biomarker–a critical appraisal of the literature. Clin Chim Acta 411:1611–1624

    Article  PubMed  CAS  Google Scholar 

  11. Pajek J, Kveder R, Gucek A, Skoberne A, Bren A, Bucar M, Cerne D, Lukac-Bajalo J (2010) Cell-free DNA in the peritoneal effluent of peritoneal dialysis solutions. Ther Apher Dial. 14:20–26

    Article  PubMed  CAS  Google Scholar 

  12. Korabecna M, Pazourkova E, Horinek A, Rocinova K, Tesar V (2013) Cell-free nucleic acids as biomarkers in dialyzed patients. J Nephrol. 26:1001–1008

    Article  PubMed  Google Scholar 

  13. Peters DL, Pretorius PJ (2011) Origin, translocation and destination of extracellular occurring DNA–a new paradigm in genetic behaviour. Clin Chim Acta 412:806–811

    Article  PubMed  CAS  Google Scholar 

  14. Atamaniuk J, Hsiao YY, Mustak M, Bernhard D, Erlacher L, Fodinger M, Tiran B, Stuhlmeier KM (2011) Analysing cell-free plasma DNA and sle disease activity. Eur J Clin Invest 41:579–583

    Article  PubMed  CAS  Google Scholar 

  15. Atamaniuk J, Ruzicka K, Stuhlmeier KM, Karimi A, Eigner M, Mueller MM (2006) Cell-free plasma DNA: a marker for apoptosis during hemodialysis. Clin Chem 52:523–526

    Article  PubMed  CAS  Google Scholar 

  16. Korabecna M, Opatrna S, Wirth J, Rulcova K, Eiselt J, Sefrna F, Horinek A (2008) Cell-free plasma DNA during peritoneal dialysis and hemodialysis and in patients with chronic kidney disease. Ann NY Acad Sci 1137:296–301

    Article  PubMed  CAS  Google Scholar 

  17. Opatrna S, Wirth J, Korabecna M, Sefrna F (2009) Cell-free plasma DNA during hemodialysis. Ren Fail 31:475–480

    Article  PubMed  CAS  Google Scholar 

  18. Ozkaya O, Bek K, Bedir A, Acikgoz Y, Ozdemir T (2009) Plasma cell-free DNA levels in children on peritoneal dialysis. Nephron Clin Pract. 113:c258–c261

    Article  PubMed  CAS  Google Scholar 

  19. Dwivedi DJ, Toltl LJ, Swystun LL, Pogue J, Liaw KL, Weitz JI, Cook DJ, Fox-Robichaud AE, Liaw PC (2012) Prognostic utility and characterization of cell-free DNA in patients with severe sepsis. Crit Care 16:R151

    Article  PubMed  PubMed Central  Google Scholar 

  20. Baroni G, Schuinski A, de Moraes TP, Meyer F, Pecoits-Filho R (2012) Inflammation and the peritoneal membrane: causes and impact on structure and function during peritoneal dialysis. Mediators Inflamm 2012:912595

    Article  PubMed  PubMed Central  Google Scholar 

  21. Catalan MP, Reyero A, Egido J, Ortiz A (2001) Acceleration of neutrophil apoptosis by glucose-containing peritoneal dialysis solutions: role of caspases. J Am Soc Nephrol 12:2442–2449

    PubMed  CAS  Google Scholar 

  22. Wang HH, Li PC, Huang HJ, Lee TY, Lin CY (2011) Peritoneal dialysate effluent during peritonitis induces human cardiomyocyte apoptosis by regulating the expression of gata-4 and bcl-2 families. J Cell Physiol 226:94–102

    Article  PubMed  CAS  Google Scholar 

  23. Rhodes A, Wort SJ, Thomas H, Collinson P, Bennett ED (2006) Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care 10:R60

    Article  PubMed  PubMed Central  Google Scholar 

  24. Saukkonen K, Lakkisto P, Varpula M, Varpula T, Voipio-Pulkki LM, Pettila V, Pulkki K (2007) Association of cell-free plasma DNA with hospital mortality and organ dysfunction in intensive care unit patients. Intensive Care Med 33:1624–1627

    Article  PubMed  CAS  Google Scholar 

  25. Saukkonen K, Lakkisto P, Pettila V, Varpula M, Karlsson S, Ruokonen E, Pulkki K (2008) Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock. Clin Chem 54:1000–1007

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

No authors have reported a conflict of interest.

Ethical approval

This study was performed in accordance with the Declaration of Helsinki. The protocol and consent form were approved by the Ethics Committee of San Bortolo Hospital (Del.n.327, 8/2014).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Grazia Maria Virzì.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Virzì, G.M., Milan Manani, S., Brocca, A. et al. Peritoneal Cell-free DNA: an innovative method for determining acute cell damage in peritoneal membrane and for monitoring the recovery process after peritonitis. J Nephrol 29, 111–118 (2016). https://doi.org/10.1007/s40620-015-0212-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-015-0212-2

Keywords

Navigation